LogicBio Therapeutics logo
LogicBio Therapeutics LOGC
$ 6.73 0.0%

Quarterly report 2022-Q3
added 11-14-2022

report update icon

LogicBio Therapeutics Financial Statements 2011-2024 | LOGC

Annual Financial Statements LogicBio Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

64.8 M 190 M 226 M 50.9 M - - - - - - -

Shares

32.4 M 23.6 M 22.6 M 5.8 M - - - - - - -

Historical Prices

2.31 7.63 7.2 10.4 - - - - - - -

Net Income

-40 M -32.6 M -40.1 M -17.6 M -5.8 M -3.43 M - - - - -

Revenue

5.41 M 3.45 M - - - - - - - - -

Cost of Revenue

- - - - - - - - - - -

Gross Profit

- 3.45 M - - - - - - - - -

Operating Income

-39 M -31.5 M -41 M -17.9 M -5.85 M - - - - - -

Interest Expense

1.07 M 1.1 M 546 K 2 K 67 K - - - - - -

EBITDA

-38.4 M -31 M -40.8 M -17.9 M -5.81 M -3.39 M - - - - -

Operating Expenses

44.4 M 35 M 41 M 17.9 M - - - - - - -

General and Administrative Expenses

16.2 M 12.2 M 10.4 M 6.86 M 2.3 M 1.37 M - - - - -

All numbers in USD currency

Quarterly Income Statement LogicBio Therapeutics

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- 33 M 33 M 33 M 33 M 32.4 M 32.2 M 31.9 M 31.8 M 23.6 M 23.3 M 23.2 M 23 M 22.7 M 22.5 M 22.3 M 22.2 M 2.14 M 1.96 M 1.79 M 1.61 M 1.48 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- -5.78 M -5.04 M -6.66 M - -10.2 M -10.5 M -10.3 M - -8.04 M -8.23 M -9.46 M - -10.9 M -10 M -40.1 M - -4.67 M -3.59 M -2.3 M - -1.04 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- 2.72 M 3.2 M 2.82 M - 2.12 M 802 K 461 K - 926 K 965 K 1.02 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- -5.74 M -4.89 M -6.45 M - -9.94 M -10.2 M -10 M - -7.77 M -7.96 M -9.34 M - -11 M -10.5 M -8.12 M - -4.55 M -3.64 M -2.37 M - -1.05 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- 176 K 197 K 218 K - 270 K 283 K 271 K - 276 K 273 K 272 K - 271 K -1 K - - 1 K -7 K 3 K - 37 K - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -5.24 M -4.55 M -6.28 M - -9.49 M -9.93 M -9.88 M - -7.42 M -7.73 M -9.24 M - -10.8 M -10.4 M -8.08 M - -4.5 M -3.6 M -2.36 M - -1.02 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- 8.46 M 8.09 M 9.26 M - 12.1 M 11 M 10.5 M - 8.69 M 8.92 M 10.4 M - 11 M 10.5 M 8.12 M - 4.55 M 3.64 M 2.37 M - 1.05 M - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- 3.41 M 3.26 M 3.62 M - 4.26 M 3.76 M 4.06 M - 3.2 M 3.03 M 3.19 M - 2.18 M 2.52 M 2.63 M - 2.12 M 1.42 M 918 K - 470 K - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency